Dasatinib price after medical insurance in 2024

Dasatinib (Dasatinib), also known as Sprycel, is an anti-tumor drug developed and produced by Bristol-Myers Squibb Company. It is a polytyrosine kinase inhibitor and is mainly used to treat patients with Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) who are resistant or intolerant to imatinib mesylate, including adult patients in the chronic phase, accelerated phase and blast phase (blast myeloblastosis and blast crisis). In addition, dasatinib is approved for the treatment of Ph chromosome-positive acute lymphoblastic leukemia (ALL) that is refractory to or intolerant to other therapies.

In terms of drug properties, dasatinib is a gray to yellow solid chemical with a specific chemical name and molecular formula. In its clinical application, dasatinib can inhibit a variety of kinases, includingBCR-ABL kinase and SRC family kinases, thereby inhibiting the proliferation of leukemia cells. However, it does not inhibit the proliferation of normal red blood cells, white blood cells, and platelets.

Regarding the method of administration of dasatinib, it is usually administered orally, and patients need to take standardized medication according to the guidance of their doctor. When taking the medicine, you need to pay attention to monitoring possible side effects, including but not limited to fatigue, headache, diarrhea, rash, etc. Some patients may experience more serious side effects, such as thrombocytopenia, abnormal liver function, etc., so regular blood tests are necessary.

Regarding price, after dasatinib entered medical insurance, its price has dropped significantly compared with the initial stage of listing. Currently, the price of a box of dasatinib is about RMB 8,000, but it should be noted that the reimbursement ratios of medical insurance may vary in different regions, so the actual costs borne by patients will also be different. In addition, there are some other versions of dasatinib on the market, such as the Indian version or the Bangladeshi version. The price may be relatively low, but patients need to pay attention to the source and quality of the drug when choosing.